Levodopa or D2 agonist induced dyskinesia in MPTP monkeys: correlation with changes in dopamine and GABAA, receptors in the striatopallidal complex
- 22 May 1995
- journal article
- Published by Elsevier in Brain Research
- Vol. 680 (1-2), 43-52
- https://doi.org/10.1016/0006-8993(95)00229-j
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Colocalization of D1 and D2 dopamine receptor mRNAs in striatal neuronsBrain Research, 1993
- Continuous lisuride effects on central dopaminergic mechanisms in Parkinson's diseaseAnnals of Neurology, 1992
- Effect of chronic treatment with (+)-PHNO, a D2 agonist in MPTP-treated monkeysExperimental Neurology, 1992
- D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal NeuronsScience, 1990
- Sustained-release (+)-PHNO [MK-458 (HPMC)] in the treatment of Parkinson's disease: Evidence for tolerance to a selective D2-receptor agonist administered as a long-acting formulationMovement Disorders, 1990
- Continuous and intermittent levodopa differentially affect basal ganglia functionAnnals of Neurology, 1989
- The functional anatomy of basal ganglia disordersTrends in Neurosciences, 1989
- Changes in local cerebral glucose utilization associated with Parkinson's syndrome induced by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) in the primateLife Sciences, 1987
- Changes of the striatal 3H-spiperone binding 3–6 weeks after nigrostriatal denervation and after two yearsLife Sciences, 1985
- L-DOPA reverses the elevated density of D2 dopamine receptors in Parkinson's diseased striatumJournal of Neural Transmission, 1985